结膜下注射贝伐珠单抗损害小鼠角膜神经支配与上皮创伤愈合
研究在小鼠中观察结膜下注射贝伐珠单抗对角膜神经、敏感性和上皮创伤愈合的影响。结果显示注射导致角膜神经变性、敏感性减弱及上皮愈合和神经再生延迟,且随浓度和次数增加更明显;单次注射1至5 mg/mL后可逐渐恢复,而补充PEDF、NGF或CNTF可减轻上述损害。
要点
- 结膜下注射贝伐珠单抗可致小鼠角膜神经变性、敏感性减弱及上皮愈合延迟。
- 损害程度随贝伐珠单抗浓度和注射次数增加而更明显。
- 补充PEDF、NGF或CNTF可减轻贝伐珠单抗所致角膜神经和上皮损害。
核心结论
- 结膜下注射贝伐珠单抗损害正常小鼠角膜神经支配、上皮创伤愈合和神经再生,可能由角膜神经营养因子含量减少所致。
研究设计与样本
- 成年C57BL/6小鼠接受结膜下注射1、2、5或25 mg/mL贝伐珠单抗。
- 采用全mount抗β3-微管蛋白荧光染色观察角膜神经,Cochet-Bonnet触觉计测量角膜敏感性。
- ELISA检测PEDF、NGF、GDNF和CNTF蛋白水平,荧光素染色评估角膜上皮创伤愈合率。
- 通过共注射PEDF、NGF或CNTF评估贝伐珠单抗所致角膜神经支配和上皮愈合损害的恢复情况。
主要发现
- 结膜下注射贝伐珠单抗引起正常小鼠明显角膜神经变性、角膜敏感性减弱及角膜上皮创伤愈合和神经再生延迟,随贝伐珠单抗浓度和注射次数增加更显著。
- 单次注射1至5 mg/mL贝伐珠单抗的小鼠角膜神经和敏感性逐渐改善并恢复。
- 贝伐珠单抗注射显著降低角膜PEDF、NGF和CNTF含量,而外源性补充PEDF、NGF或CNTF减轻结膜下注射贝伐珠单抗后角膜神经、敏感性和上皮创伤愈合的损害。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the effects of subconjunctival bevacizumab injection on the corneal nerve, sensitivity, and epithelial wound healing in mice. METHODS: Adult C57BL/6 mice were treated with subconjunctival injection of 1, 2, 5, or 25 mg/mL bevacizumab. The corneal nerve was observed with whole-mount anti-β3-tubulin fluorescence staining. Corneal sensitivity was measured with a Cochet-Bonnet esthesiometer. The protein levels of pigment epithelium-derived factor (PEDF), nerve growth factor (NGF), glial-derived neurotrophic factor (GDNF), and ciliary neurotrophic factor (CNTF) were measured by ELISA. The corneal epithelial wound-healing rate was evaluated by fluorescein staining. The recovery of impaired mouse corneal innervations and epithelial wound-healing rate following bevacizumab injection was evaluated with the co-injection of PEDF, NGF, or CNTF. RESULTS: Subconjunctival bevacizumab injection caused apparent corneal nerve degeneration, attenuated corneal sensitivity, and delayed corneal epithelial wound healing and nerve regeneration in normal mice, which was more significant with increased concentration and times of the bevacizumab injection. However, the corneal nerve and sensitivity gradually improved and recovered in mice with a single injection of 1 to 5 mg/mL bevacizumab. Moreover, the bevacizumab injection significantly decreased the corneal PEDF, NGF, and CNTF content, whereas exogenous PEDF, NGF, or CNTF supplement attenuated impairment of the corneal nerve, sensitivity, and epithelial wound healing after subconjunctival bevacizumab injection. CONCLUSIONS: Subconjunctival bevacizumab injection impairs corneal innervations, epithelial wound healing, and nerve regeneration in normal mice, which may be caused by the reduction of neurotrophic factor content in the cornea.
引用
- Dong M, Di G, Zhang X, et al. Subconjunctival Bevacizumab Injection Impairs Corneal Innervations and Epithelial Wound Healing in Mice. Invest Ophthalmol Vis Sci. 2017. PMID: 28265643. doi:10.1167/iovs.16-20926
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。